Nektar Therapeutics 10-K for FY2024
Nektar Therapeutics (NKTR)
10-K
2025-03-14
For: 2024-12-31
View Original
Added on
April 04, 2026
About this 10-K
Nektar Therapeutics filed this 10-K on March 14, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $98.43M
- up 9.2% from $90.12M a year earlier
- Net loss
- $118.96M
- compared with a net loss of $276.06M a year earlier
- Diluted EPS
- -$0.58
- compared with -$1.45 a year earlier